Certara’s training solutions ensure professionals advance their skills by providing practical knowledge and hands-on training while working with leading PK/PD and biosimulation tools.
PK/PD 和生物模拟培训
Advance your PK/PD expertise with Certara’s training programs
Flexible and comprehensive Modeling and Simulation training
Certara offers accessible training programs tailored for both novices and experts in drug development. Learn at your own pace, enhance your skills, and succeed in your career.
Gain the skills to advance your career and impact
Certara 大学
Enroll in flexible PK/PD courses—live online, on-demand, and in person—to master PK/PD concepts and Phoenix Platform software. Many courses earn you globally recognized certifications.
了解更多信息
Simcyp PBPK workshops
Led by world-leading experts in mechanistic modeling. Available online and in person.
了解更多信息
Industry-leading training designed for professionals
Gain skills and Certification from Certara University
More than 4000 scientists take at least one Certara University course every year, on topics ranging from NCA and popPK to trial simulation. These courses are designed for both novices and advanced users of our industry leading Phoenix platform for managing, analyzing and reporting pharmacokinetic (PK), pharmacodynamics (PD) and toxicokinetic (TK) data.
Many Certara University courses grant you online accreditation of user competency and proficiency in the analysis of PK/PD data, Phoenix WinNonlin and Phoenix NLME.
Understand mechanistic modeling and simulation with Simcyp PBPK workshops
Quantitative and model-informed drug development is transforming the way the FDA and other regulatory agencies evaluate efficiency and innovation in the industry. Our workshops equip professionals with cutting-edge methodologies that combine compound-specific in vitro and in vivo data with systems biology to precisely simulate and analyze drug behavior across diverse target populations. This integrated approach supports pivotal decisions for Investigational New Drug (IND) and New Drug Applications (NDA) submissions while optimizing the design and execution of clinical studies.
Tailored particularly for senior managers and scientists, they offer a strong foundation in model-informed strategies, ensuring attendees are equipped to lead with confidence and innovation in a rapidly evolving landscape.
